Showing results (1-10 of 250) with videos related to
Sort By:
Pageof 25
Current Opinion in Lipidology|July 14, 2010
Fibrates: no ACCORD on their use in the treatment of dyslipidaemiaAnthony S WierzbickiDiabetes & Vascular Disease Research|July 27, 2007
Homocysteine and cardiovascular disease: a review of the evidenceAnthony S WierzbickiInternational Journal of Clinical Practice|December 21, 2004
Lipid-altering agents: the futureA S WierzbickiExpert Opinion on Investigational Drugs|October 27, 2004
Lipid-lowering therapies in developmentAnthony S WierzbickiInternational Journal of Clinical Practice|May 27, 1999
The role of lipid lowering in transplantationA S WierzbickiCurrent Opinion in Cardiology|May 9, 2009
Fibrates in the treatment of cardiovascular risk and atherogenic dyslipidaemiaAnthony S WierzbickiExpert Review of Neurotherapeutics|October 9, 2009
Stroke in systemic lupus erythematosusAnthony S WierzbickiLupus|April 24, 2001
Lipid-lowering drugs in lupus: an unexplored therapeutic interventionA S WierzbickiInternational Journal of Clinical Practice|April 20, 2006
FIELDS of dreams, fields of tears: a perspective on the fibrate trialsA S WierzbickiCurrent Opinion in Lipidology|August 15, 2017
The challenges of proprotein convertase subtilisin-kexin-9 inhibitors for lipid guidelines and models of careAnthony S WierzbickiPageof 25